Newly published research has revealed a close link between proteins associated with Alzheimer's disease and age-related sight loss. The findings could open the way to new treatments for patients with deteriorating vision ...
Mar 10, 2021
1
258
Scientists at Trinity College Dublin have made a major breakthrough with important implications for sufferers of the eye disease Age-Related Macular Degeneration (AMD), which can cause central blindness in sufferers.
Apr 2, 2014
1
2
A revolutionary new treatment for cataracts has shown extremely positive results in laboratory tests, giving hope that the condition, which currently can only be cured with surgery, could soon be treated with drugs.
May 16, 2022
0
979
Age-related macular degeneration (AMD) is one the most prevalent eye diseases. In the late stage of the disease, newly formed vessels in the retina alter its structure, which leads to blurry and distorted vision. This condition ...
The first human corneas have been 3-D printed by scientists at Newcastle University, UK.
May 29, 2018
0
2644
Scientists at the University of Birmingham are one step closer to developing an eye drop that could revolutionise treatment for age-related macular degeneration (AMD).
Jul 19, 2018
0
1795
Today's cataract surgery is often described as a marvel of modern medicine, a one-hour outpatient procedure that has spared millions from blindness, especially in developed countries.
Nov 5, 2018
0
10
Perception is not objective reality. Case in point: The above image is stationary and flat …just try telling your brain that. In his new book, The Case Against Reality, UCI cognitive scientist Donald Hoffman applies this ...
Jul 23, 2019
1
3492
Ophthalmologist and retinal surgeon Dimitra Skondra, MD, Ph.D., knows that developing any new treatment can be fraught with false hopes and unexpected setbacks. She is cautiously optimistic, however, that a new method she ...
Oct 24, 2019
0
58
A case of pink eye is now reason to be tested for COVID-19, according to University of Alberta researchers.
Jun 18, 2020
0
5311
